Terms ending in 2027
Every in-force patent on AbbVie Inc.'s record whose computed term ends in 2027, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 7,632,946 | Naphthyridine-Based Antibacterial Compositions In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 7,910,595 | Anti-Viral Compounds In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 8,586,746 | Amino-Aza-Adamantane Derivatives and Methods of Use In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 9,540,432 | Anti-Aß Globulomer 7C6 Antibodies In force · Medium confidence | AbbVie Deutschland GmbH & Co. KG | In force | Medium confidence | |
| US 7,642,260 | Apoptosis Promoters In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 7,956,185 | CYCLOBUT-3-ENE-1,2,-Dione Inhibitors of Polo-Like Kinases In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 7,662,958 | Anti-Infective Agents In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 7,951,800 | Anti-Infective Agents In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 7,973,161 | Apoptosis Promoters In force · Medium confidence | AbbVie Inc. | In force | Medium confidence | |
| US 7,999,117 | Substituted 1H-BENZIMIDAZOLE-4-Carboxamides Are Potent Parp Inhibitors In force · High confidence | AbbVie Inc. | In force | High confidence | |
| 21 more term ends in 2027 · Pro | |||||
10 of 31 patents shown. Soonest term end first, then patent number.
Pro members see all 31, all of them expiring within the 18 months from Nov 21, 2026.
30 of these are in force and held by AbbVie Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.